Literature DB >> 14715741

Molecular analysis of Mycobacterium kansasii isolates from the United States.

Yansheng Zhang1, Linda B Mann, Rebecca W Wilson, Barbara A Brown-Elliott, Véronique Vincent, Yoshitsugu Iinuma, Richard J Wallace.   

Abstract

We studied the population genetics of Mycobacterium kansasii isolates from the United States by PCR restriction enzyme analysis (PRA) of the 441-bp Telenti fragment of the hsp-65 gene and pulsed-field gel electrophoresis (PFGE) of genomic DNA with the restriction endonucleases AseI, DraI, and XbaI, and we compared the patterns to those previously reported from France and Japan. By PRA, 78 of 81 clinical isolates (96%) from the United States belonged to subspecies I. With PFGE, 28 AseI patterns, 32 DraI patterns, and 35 XbaI patterns were produced. PFGE showed marked clonality of the U.S. isolates, with differences between genotypes involving only one or two bands. Isolates within Texas showed lower pattern diversity than those from different states. With DraI, 31 of 71 isolates (44%) had the same common PFGE pattern, which matched the predominant pattern in France (pattern Ia), determined by Picardeau et al. (M. Picardeau, G. Prod'hom, L. Raskine, M. P. LePennec, and V. Vincent, J. Clin. Microbiol. 35:25-32, 1997), and in Japan (type M), determined by Iinuma et al. (Y. Iinuma, S. Ichiyama, Y. Hasegawa, K. Shimokata, S. Kawahara, and T. Matsushima, J. Clin. Microbiol. 35:596-599, 1997). With AseI, 42% of isolates produced a common pattern indistinguishable from the common pattern seen in French isolates (Ia) and with only one band difference from the common pattern (type M) in Japan. This study demonstrates that subspecies I is the predominant subspecies of M. kansasii among clinical isolates in the United States, as it is in Europe and Japan, and that genotype I is highly clonal worldwide, with the same major genotype responsible for human infection. The fact that a single clone of M. kansasii is responsible for most cases of human disease suggests that specific virulence factors may be associated with this specific genotype.

Entities:  

Mesh:

Year:  2004        PMID: 14715741      PMCID: PMC321655          DOI: 10.1128/JCM.42.1.119-125.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Large-restriction-fragment analysis of Mycobacterium kansasii genomic DNA and its application in molecular typing.

Authors:  Y Iinuma; S Ichiyama; Y Hasegawa; K Shimokata; S Kawahara; T Matsushima
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Mycobacterium kansasii and human immunodeficiency virus co-infection in London.

Authors:  J L Klein; E L Corbett; P M Slade; R F Miller; R J Coker
Journal:  J Infect       Date:  1998-11       Impact factor: 6.072

3.  Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis.

Authors:  O Lortholary; F Deniel; P Boudon; M P Le Pennec; M Mathieu; M Soilleux; C Le Pendeven; P Loiseau; V Vincent; D Valeyre
Journal:  Int J Tuberc Lung Dis       Date:  1999-01       Impact factor: 2.373

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.

Authors:  E L Corbett; M Hay; G J Churchyard; P Herselman; T Clayton; B G Williams; R Hayes; D Mulder; K M De Cock
Journal:  Int J Tuberc Lung Dis       Date:  1999-06       Impact factor: 2.373

6.  Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies.

Authors:  F Alcaide; I Richter; C Bernasconi; B Springer; C Hagenau; R Schulze-Röbbecke; E Tortoli; R Martín; E C Böttger; A Telenti
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.

Authors:  V Pintado; E Gómez-Mampaso; P Martín-Dávila; J Cobo; E Navas; C Quereda; J Fortún; A Guerrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-08       Impact factor: 3.267

8.  Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.

Authors:  K C Bloch; L Zwerling; M J Pletcher; J A Hahn; J L Gerberding; S M Ostroff; D J Vugia; A L Reingold
Journal:  Ann Intern Med       Date:  1998-11-01       Impact factor: 25.391

9.  Identification of a genetically distinct subspecies of Mycobacterium kansasii.

Authors:  B C Ross; K Jackson; M Yang; A Sievers; B Dwyer
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis.

Authors:  R J Wallace; Y Zhang; B A Brown; D Dawson; D T Murphy; R Wilson; D E Griffith
Journal:  Am J Respir Crit Care Med       Date:  1998-10       Impact factor: 21.405

View more
  13 in total

1.  Evaluation of the GenoType Mycobacterium Assay for identification of mycobacterial species from cultures.

Authors:  Elvira Richter; Sabine Rüsch-Gerdes; Doris Hillemann
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.

Authors:  Fernando Alcaide; Laura Calatayud; Miguel Santín; Rogelio Martín
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

4.  Combined rpoB duplex PCR and hsp65 PCR restriction fragment length polymorphism with capillary electrophoresis as an effective algorithm for identification of mycobacterial species from clinical isolates.

Authors:  Chen-Cheng Huang; Jiann-Hwa Chen; Shiau-Ting Hu; Chien-Shun Chiou; Wei-Chang Huang; Jeng-Yuan Hsu; Jang-Jih Lu; Gwan-Han Shen
Journal:  BMC Microbiol       Date:  2012-07-08       Impact factor: 3.605

5.  Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the hsp65 gene.

Authors:  Zofia Bakuła; Aleksandra Safianowska; Magdalena Nowacka-Mazurek; Jacek Bielecki; Tomasz Jagielski
Journal:  Biomed Res Int       Date:  2013-12-22       Impact factor: 3.411

6.  Molecular typing of Mycobacterium kansasii using pulsed-field gel electrophoresis and a newly designed variable-number tandem repeat analysis.

Authors:  Zofia Bakuła; Anna Brzostek; Paulina Borówka; Anna Żaczek; Izabela Szulc-Kiełbik; Agata Podpora; Paweł Parniewski; Dominik Strapagiel; Jarosław Dziadek; Małgorzata Proboszcz; Jacek Bielecki; Jakko van Ingen; Tomasz Jagielski
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

7.  Comparative Genomic and Transcriptomic Analyses of Mycobacterium kansasii Subtypes Provide New Insights Into Their Pathogenicity and Taxonomy.

Authors:  Qingtian Guan; Roy Ummels; Fathia Ben-Rached; Yara Alzahid; Mohammad S Amini; Sabir A Adroub; Jakko van Ingen; Wilbert Bitter; Abdallah M Abdallah; Arnab Pain
Journal:  Front Cell Infect Microbiol       Date:  2020-03-24       Impact factor: 5.293

8.  Pathogenic Determinants of the Mycobacterium kansasii Complex: An Unsuspected Role for Distributive Conjugal Transfer.

Authors:  Florian Tagini; Trestan Pillonel; Claire Bertelli; Katia Jaton; Gilbert Greub
Journal:  Microorganisms       Date:  2021-02-10

Review 9.  Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria.

Authors:  Tomasz Jagielski; Jakko van Ingen; Nalin Rastogi; Jarosław Dziadek; Paweł K Mazur; Jacek Bielecki
Journal:  Biomed Res Int       Date:  2014-01-05       Impact factor: 3.411

10.  Genomic Insights Into the Mycobacterium kansasii Complex: An Update.

Authors:  Tomasz Jagielski; Paulina Borówka; Zofia Bakuła; Jakub Lach; Błażej Marciniak; Anna Brzostek; Jarosław Dziadek; Mikołaj Dziurzyński; Lian Pennings; Jakko van Ingen; Manca Žolnir-Dovč; Dominik Strapagiel
Journal:  Front Microbiol       Date:  2020-01-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.